Guiding age-specific recommendations for pediatric cancers

UC Davis Comprehensive Cancer Center epidemiologists led a novel analysis of more than 1 million U.S. cancer patients last year, and found that second cancers in children and in adolescents and young adults (AYA) are far deadlier than they are in older adults – and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall. Their study in JAMA Oncology also found that survival after almost all types of cancer is much higher when the cancer is a primary malignancy, and that survival differences are most pronounced in patients under age 40.

Our researchers hope the findings will help guide clinicians in providing age-specific recommendations on prevention, screening, treatment and survivorship – especially among the AYA population, whose survival rates have not improved to the same extent as for children and older adults.

Related Information:

"Reese feels very supported — and we do, too. For as sad as (a pediatric cancer diagnosis) is, there have been many positives." – Lisa Baker, whose daughter Reese recently completed leukemia treatment. Reese received an American Girl doll without hair from the Children’s Miracle Network, which donates them to chemotherapy patients so they can experience treatment together.